A Duty to Deceive: Placebos in Clinical Practice
Author:
- 9 December 2009
- journal article
- research article
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 9 (12) , 4-12
Abstract
Among medical researchers and clinicians the dominant view is that it is unethical to deceive patients by prescribing a placebo. This opinion is formalized in a recent policy issued by the American Medical Association (AMA [Chicago, IL]). Although placebos can be shown to be always safe, often effective, and sometimes necessary, doctors are now effectively prohibited from using them in clinical practice. I argue that the deceptive administration of placebos is not subject to the same moral objections that face other forms of deception in clinical practice and medical research. Although deception is normally objectionable on the grounds that it limits autonomy and breaches trust, these grounds do not apply to placebos when they are prescribed within appropriate ethical limits. Patients have reason to prefer that doctors can prescribe placebos in ethically responsible ways. Hence, the AMA has an obligation to endorse and to promote the responsible use of deceptive placebos in clinical practice.Keywords
This publication has 30 references indexed in Scilit:
- Placebos and painkillers: is mind as real as matter?Nature Reviews Neuroscience, 2005
- Pain and the Placebo: What We Have LearnedPerspectives in Biology and Medicine, 2005
- The ethics of the placebo in clinical practiceJournal of Medical Ethics, 2004
- Placebo and Opioid Analgesia-- Imaging a Shared Neuronal NetworkScience, 2002
- Codes and DeclarationsNursing Ethics, 2002
- Placebos in clinical practice and research.Journal of Medical Ethics, 1996
- The placebo in general practiceThe Lancet, 1994
- Harnessing placebo effects in health careThe Lancet, 1994
- The importance of placebo effects in pain treatment and research1994
- Placebo pain medication. Ethical and practical considerationsArchives of Family Medicine, 1994